The study combined NLR with rapid field assessment metrics for APE (cardiac troponin I, cTnI and N-terminal pro-brain natriuretic peptide, NT-proBNP) to create a right ventricular dysfunction risk score formula to predict right ventricular dysfunction and 30-day mortality in patients with APE more accurately [97]. The gene discussed is NPPB; the disease is apparent mineralocorticoid excess.